Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Abstract The incidence of neurodegenerative diseases (NDs) has increased recently. However, most of the current governance strategies are palliative and lack effective therapeutic drugs. Therefore, elucidating the pathological mechanism of NDs is the key to the development of targeted drugs. As a me...
Saved in:
Main Authors: | Jiao Pang, Changqian Cen, Yuan Tian, Xingrui Cao, Liang Hao, Xueshu Tao, Zhipeng Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-024-03222-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phospholipase D, a Novel Therapeutic Target Contributes to the Pathogenesis of Neurodegenerative and Neuroimmune Diseases
by: Weiwei Zhang, et al.
Published: (2024-01-01) -
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
by: Ya-Min Ma, et al.
Published: (2023-01-01) -
Retraction: Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases.
by: PLOS ONE Editors
Published: (2024-01-01) -
LPAR3: a shared target for neurodegenerative diseases?
by: Susan Acton, et al.
Published: (2025-12-01) -
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
by: Rupal Dhariwal, et al.
Published: (2025-01-01)